HEALEY ALS Platform Trial - Drug Development Pipeline and Selection Process
MassGeneralHospital via YouTube
Master Windows Internals - Kernel Programming, Debugging & Architecture
You’re only 3 weeks away from a new language
Overview
Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Learn about the latest developments in ALS drug research through this webinar featuring Dr. Sabrina Paganoni from Massachusetts General Hospital. Discover how the drug development pipeline works in ALS research and understand the systematic approach used to select new treatment regimens for the HEALEY ALS Platform Trial. Gain insights into cutting-edge research methodologies being employed to accelerate the discovery of effective ALS treatments. Explore the innovative platform trial design that allows multiple potential therapies to be tested simultaneously, potentially speeding up the path to finding effective treatments for patients with amyotrophic lateral sclerosis. Access expert knowledge from one of the leading ALS research centers and get your questions answered about current and future therapeutic approaches in this devastating neurodegenerative disease.
Syllabus
HEALEY ALS Platform Trial Webinar: December 18, 2025 | Mass General Hospital
Taught by
MassGeneralHospital